Pharming Group NV

PHAR · Euronext Amsterdam🇳🇱

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 19 days ago

Total Revenue

€92.7M

Previous year: €81.2M

+14.2%

EPS

€0.005

Previous year: -€0.04

Loading...

Pharming Group NV

Unlock previous datapoints

Upgrade

Pharming Group NV

Unlock previous datapoints

Upgrade

Pharming Group NV Revenue by Segment

Pharming Group NV Revenue by Geographic Location

Revenue by Segment

RUCONEST® (US) Revenue

CapyFin.com

RUCONEST® (EU & RoW) Revenue

CapyFin.com

Joenja® (US) Revenue

CapyFin.com

Joenja® (EU & RoW) Revenue

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

EU & Rest of World Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.15B

P/E Ratio

-6.03

Sector

N/A

Industry

N/A

52-Week High

$1.77

52-Week Low

$0.688

Operating Margin

7.2%

Gross Profit Margin

86.8%

Net Profit Margin

4%

Products

Get in Touch

Resources

Pharming Group NV

Pharming Group NV

Pharming Group NV

Pharming Group NV Revenue by Segment

Pharming Group NV Revenue by Geographic Location

Revenue by Segment

RUCONEST® (US) Revenue

RUCONEST® (EU & RoW) Revenue

Joenja® (US) Revenue

Joenja® (EU & RoW) Revenue

Revenue by Geographic Location

United States Revenue

EU & Rest of World Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics